(LINE) Lineage, Common Stock - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US53566V1061
Stock: Cold Storage, Logistics, Sustainability, Supply Chain
Total Rating 29
Risk 52
Buy Signal -0.02
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.99% |
| Yield on Cost 5y | 2.89% |
| Yield CAGR 5y | 132.60% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 38.4% |
| Relative Tail Risk | -5.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.82 |
| Alpha | -44.76 |
| Character TTM | |
|---|---|
| Beta | 0.852 |
| Beta Downside | 0.583 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.80% |
| CAGR/Max DD | -0.56 |
Description: LINE Lineage, Common Stock January 04, 2026
Lineage, Inc. (NASDAQ: LINE) is the world’s largest temperature-controlled warehouse REIT, operating over 485 facilities that together provide roughly 88 million sq ft (≈ 3.1 bn cu ft) of refrigerated space across North America, Europe, and Asia-Pacific. Founded in 2015 and headquartered in Novi, Michigan, the company delivers end-to-end supply-chain services and technology to food-and-beverage manufacturers, retailers, and distributors, aiming to boost distribution efficiency, enhance sustainability, and cut waste.
Key operating metrics (as of the latest 10-K) show an occupancy rate near 96 % and a weighted-average lease term of 7.5 years, indicating a stable cash-flow profile. The cold-storage sector is being driven by rising e-commerce food sales, which have grown at a CAGR of 12 % since 2020, and by regulatory pressure on food-safety and carbon-emissions, both of which support higher demand for modern, energy-efficient facilities.
For a deeper, data-rich view of LINE’s valuation dynamics, consider exploring the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -177.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.73 > 1.0 |
| NWC/Revenue: -0.17% < 20% (prev 1.95%; Δ -2.12% < -1%) |
| CFO/TA 0.05 > 3% & CFO 884.0m > Net Income -177.0m |
| Net Debt (7.82b) to EBITDA (999.0m): 7.83 < 3 |
| Current Ratio: 0.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (228.0m) vs 12m ago 8.57% < -2% |
| Gross Margin: 32.18% > 18% (prev 0.33%; Δ 3185 % > 0.5%) |
| Asset Turnover: 27.87% > 50% (prev 27.70%; Δ 0.16% > 0%) |
| Interest Coverage Ratio: 0.28 > 6 (EBITDA TTM 999.0m / Interest Expense TTM 343.0m) |
Altman Z'' -0.62
| A: -0.00 (Total Current Assets 1.28b - Total Current Liabilities 1.29b) / Total Assets 19.20b |
| B: -0.12 (Retained Earnings -2.33b / Total Assets 19.20b) |
| C: 0.01 (EBIT TTM 97.0m / Avg Total Assets 19.23b) |
| D: -0.25 (Book Value of Equity -2.44b / Total Liabilities 9.81b) |
| Altman-Z'' Score: -0.62 = B |
Beneish M -3.11
| DSRI: 0.95 (Receivables 857.0m/901.0m, Revenue 5.36b/5.33b) |
| GMI: 1.03 (GM 32.18% / 33.06%) |
| AQI: 0.98 (AQ_t 0.26 / AQ_t-1 0.26) |
| SGI: 1.00 (Revenue 5.36b / 5.33b) |
| TATA: -0.06 (NI -177.0m - CFO 884.0m) / TA 19.20b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of LINE shares?
As of February 07, 2026, the stock is trading at USD 38.63 with a total of 1,570,005 shares traded.
Over the past week, the price has changed by +8.18%, over one month by +7.16%, over three months by +9.35% and over the past year by -30.28%.
Over the past week, the price has changed by +8.18%, over one month by +7.16%, over three months by +9.35% and over the past year by -30.28%.
Is LINE a buy, sell or hold?
Lineage, Common Stock has received a consensus analysts rating of 3.63.
Therefor, it is recommend to hold LINE.
- StrongBuy: 4
- Buy: 5
- Hold: 9
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the LINE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 39.4 | 2.1% |
| Analysts Target Price | 39.4 | 2.1% |
| ValueRay Target Price | 40.7 | 5.3% |
LINE Fundamental Data Overview February 03, 2026
P/E Forward = 769.2308
P/S = 1.6648
P/B = 0.9798
Revenue TTM = 5.36b USD
EBIT TTM = 97.0m USD
EBITDA TTM = 999.0m USD
Long Term Debt = 5.92b USD (from longTermDebt, last quarter)
Short Term Debt = 150.0m USD (from shortTermDebt, last quarter)
Debt = 7.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.82b USD (from netDebt column, last quarter)
Enterprise Value = 16.74b USD (8.92b + Debt 7.90b - CCE 75.0m)
Interest Coverage Ratio = 0.28 (Ebit TTM 97.0m / Interest Expense TTM 343.0m)
EV/FCF = 98.48x (Enterprise Value 16.74b / FCF TTM 170.0m)
FCF Yield = 1.02% (FCF TTM 170.0m / Enterprise Value 16.74b)
FCF Margin = 3.17% (FCF TTM 170.0m / Revenue TTM 5.36b)
Net Margin = -3.30% (Net Income TTM -177.0m / Revenue TTM 5.36b)
Gross Margin = 32.18% ((Revenue TTM 5.36b - Cost of Revenue TTM 3.63b) / Revenue TTM)
Gross Margin QoQ = 32.32% (prev 31.85%)
Tobins Q-Ratio = 0.87 (Enterprise Value 16.74b / Total Assets 19.20b)
Interest Expense / Debt = 1.13% (Interest Expense 89.0m / Debt 7.90b)
Taxrate = 21.0% (US default 21%)
NOPAT = 76.6m (EBIT 97.0m * (1 - 21.00%))
Current Ratio = 0.99 (Total Current Assets 1.28b / Total Current Liabilities 1.29b)
Debt / Equity = 0.94 (Debt 7.90b / totalStockholderEquity, last quarter 8.38b)
Debt / EBITDA = 7.83 (Net Debt 7.82b / EBITDA 999.0m)
Debt / FCF = 46.01 (Net Debt 7.82b / FCF TTM 170.0m)
Total Stockholder Equity = 8.56b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.92% (Net Income -177.0m / Total Assets 19.20b)
RoE = -2.07% (Net Income TTM -177.0m / Total Stockholder Equity 8.56b)
RoCE = 0.67% (EBIT 97.0m / Capital Employed (Equity 8.56b + L.T.Debt 5.92b))
RoIC = 0.55% (NOPAT 76.6m / Invested Capital 14.03b)
WACC = 5.22% (E(8.92b)/V(16.82b) * Re(9.05%) + D(7.90b)/V(16.82b) * Rd(1.13%) * (1-Tc(0.21)))
Discount Rate = 9.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 4.07%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈113.7m ; Y1≈74.7m ; Y5≈34.1m
Fair Price DCF = N/A (negative equity: EV 1.09b - Net Debt 7.82b = -6.74b; debt exceeds intrinsic value)
EPS Correlation: 54.16 | EPS CAGR: 14.71% | SUE: 0.0 | # QB: 0
Revenue Correlation: 20.25 | Revenue CAGR: 1.30% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.21 | Chg30d=+0.005 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.72 | Chg30d=+0.001 | Revisions Net=+1 | Growth EPS=-10.9% | Growth Revenue=+1.9%
P/S = 1.6648
P/B = 0.9798
Revenue TTM = 5.36b USD
EBIT TTM = 97.0m USD
EBITDA TTM = 999.0m USD
Long Term Debt = 5.92b USD (from longTermDebt, last quarter)
Short Term Debt = 150.0m USD (from shortTermDebt, last quarter)
Debt = 7.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.82b USD (from netDebt column, last quarter)
Enterprise Value = 16.74b USD (8.92b + Debt 7.90b - CCE 75.0m)
Interest Coverage Ratio = 0.28 (Ebit TTM 97.0m / Interest Expense TTM 343.0m)
EV/FCF = 98.48x (Enterprise Value 16.74b / FCF TTM 170.0m)
FCF Yield = 1.02% (FCF TTM 170.0m / Enterprise Value 16.74b)
FCF Margin = 3.17% (FCF TTM 170.0m / Revenue TTM 5.36b)
Net Margin = -3.30% (Net Income TTM -177.0m / Revenue TTM 5.36b)
Gross Margin = 32.18% ((Revenue TTM 5.36b - Cost of Revenue TTM 3.63b) / Revenue TTM)
Gross Margin QoQ = 32.32% (prev 31.85%)
Tobins Q-Ratio = 0.87 (Enterprise Value 16.74b / Total Assets 19.20b)
Interest Expense / Debt = 1.13% (Interest Expense 89.0m / Debt 7.90b)
Taxrate = 21.0% (US default 21%)
NOPAT = 76.6m (EBIT 97.0m * (1 - 21.00%))
Current Ratio = 0.99 (Total Current Assets 1.28b / Total Current Liabilities 1.29b)
Debt / Equity = 0.94 (Debt 7.90b / totalStockholderEquity, last quarter 8.38b)
Debt / EBITDA = 7.83 (Net Debt 7.82b / EBITDA 999.0m)
Debt / FCF = 46.01 (Net Debt 7.82b / FCF TTM 170.0m)
Total Stockholder Equity = 8.56b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.92% (Net Income -177.0m / Total Assets 19.20b)
RoE = -2.07% (Net Income TTM -177.0m / Total Stockholder Equity 8.56b)
RoCE = 0.67% (EBIT 97.0m / Capital Employed (Equity 8.56b + L.T.Debt 5.92b))
RoIC = 0.55% (NOPAT 76.6m / Invested Capital 14.03b)
WACC = 5.22% (E(8.92b)/V(16.82b) * Re(9.05%) + D(7.90b)/V(16.82b) * Rd(1.13%) * (1-Tc(0.21)))
Discount Rate = 9.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 4.07%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈113.7m ; Y1≈74.7m ; Y5≈34.1m
Fair Price DCF = N/A (negative equity: EV 1.09b - Net Debt 7.82b = -6.74b; debt exceeds intrinsic value)
EPS Correlation: 54.16 | EPS CAGR: 14.71% | SUE: 0.0 | # QB: 0
Revenue Correlation: 20.25 | Revenue CAGR: 1.30% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.21 | Chg30d=+0.005 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.72 | Chg30d=+0.001 | Revisions Net=+1 | Growth EPS=-10.9% | Growth Revenue=+1.9%